Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
Conte G, Costabile G, Baldassi D, Rondelli V, Bassi R, Colombo D, Linardos G, Fiscarelli EV, Sorrentino R, Miro A, Quaglia F, Brocca P, d'Angelo I, Merkel OM, Ungaro F. Conte G, et al. Among authors: sorrentino r. ACS Appl Mater Interfaces. 2022 Feb 16;14(6):7565-7578. doi: 10.1021/acsami.1c14975. Epub 2022 Feb 2. ACS Appl Mater Interfaces. 2022. PMID: 35107987 Free PMC article.
Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
Ungaro F, d'Angelo I, Coletta C, d'Emmanuele di Villa Bianca R, Sorrentino R, Perfetto B, Tufano MA, Miro A, La Rotonda MI, Quaglia F. Ungaro F, et al. Among authors: sorrentino r. J Control Release. 2012 Jan 10;157(1):149-59. doi: 10.1016/j.jconrel.2011.08.010. Epub 2011 Aug 16. J Control Release. 2012. PMID: 21864595
Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.
Costabile G, d'Angelo I, Rampioni G, Bondì R, Pompili B, Ascenzioni F, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Miro A, Quaglia F, Imperi F, Leoni L, Ungaro F. Costabile G, et al. Among authors: sorrentino r. Mol Pharm. 2015 Aug 3;12(8):2604-17. doi: 10.1021/acs.molpharmaceut.5b00098. Epub 2015 May 27. Mol Pharm. 2015. PMID: 25974285
Large Porous Particles for Sustained Release of a Decoy Oligonucelotide and Poly(ethylenimine): Potential for Combined Therapy of Chronic Pseudomonas aeruginosa Lung Infections.
d'Angelo I, Perfetto B, Costabile G, Ambrosini V, Caputo P, Miro A, d'Emmanuele di Villa Bianca R, Sorrentino R, Donnarumma G, Quaglia F, Ungaro F. d'Angelo I, et al. Among authors: sorrentino r. Biomacromolecules. 2016 May 9;17(5):1561-71. doi: 10.1021/acs.biomac.5b01646. Epub 2016 Apr 1. Biomacromolecules. 2016. PMID: 27002689
Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
Costabile G, d'Angelo I, d'Emmanuele di Villa Bianca R, Mitidieri E, Pompili B, Del Porto P, Leoni L, Visca P, Miro A, Quaglia F, Imperi F, Sorrentino R, Ungaro F. Costabile G, et al. Among authors: sorrentino r. J Control Release. 2016 Sep 28;238:80-91. doi: 10.1016/j.jconrel.2016.07.029. Epub 2016 Jul 19. J Control Release. 2016. PMID: 27449745
606 results